{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33408019",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ijantimicag.2020.106240",
      "S0924-8579(20)30459-3"
    ],
    "Journal": {
      "ISSN": "1872-7913",
      "JournalIssue": {
        "Volume": "57",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan"
        }
      },
      "Title": "International journal of antimicrobial agents",
      "ISOAbbreviation": "Int J Antimicrob Agents"
    },
    "ArticleTitle": "Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.",
    "Pagination": {
      "StartPage": "106240",
      "MedlinePgn": "106240"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "IHU-M\u00e9diterran\u00e9e Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France."
          }
        ],
        "LastName": "Million",
        "ForeName": "Matthieu",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "IHU-M\u00e9diterran\u00e9e Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France."
          }
        ],
        "LastName": "Roussel",
        "ForeName": "Yanis",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "IHU-M\u00e9diterran\u00e9e Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, VITROME, Marseille, France."
          }
        ],
        "LastName": "Gautret",
        "ForeName": "Philippe",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "IHU-M\u00e9diterran\u00e9e Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France. Electronic address: Didier.raoult@gmail.com."
          }
        ],
        "LastName": "Raoult",
        "ForeName": "Didier",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Letter",
      "Meta-Analysis"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Int J Antimicrob Agents",
    "NlmUniqueID": "9111860",
    "ISSNLinking": "0924-8579"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antimalarials"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Combinations"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    },
    {
      "RegistryNumber": "4QWG6N8QKH",
      "NameOfSubstance": "Hydroxychloroquine"
    },
    {
      "RegistryNumber": "83905-01-5",
      "NameOfSubstance": "Azithromycin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antimalarials"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Azithromycin"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Combinations"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Synergism"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Hydroxychloroquine"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Nasopharynx"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "genetics"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Statistics as Topic"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Viral Load"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "Declaration of Competing Interest The authors declare no competing interests."
}